Trademark: TILSEQ 1735581
Word
TILSEQ
ID
1735581
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
09 April 2015
Registration Date
09 April 2015
Cancellation Date
28 November 2018
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 42:
Scientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; providing scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
Scientific research in the field of immune sequencing and analytic services; scientific research in the field of immune repertoire quantitation and sequencing services; medical and scientific research in the field of cancer biology; providing medical and scientific research information in the fields of immune sequencing, cancer biology, pharmaceuticals, and vaccine development; research and development in the fields of cancer biology, vaccines, immunology, pharmaceutical and biotechnology; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; providing scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors
Class 44:
Providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses too immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes
Providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses too immunotherapy or cancer treatment; providing medical quantitative and diagnostic testing services in the field of cancer biology; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes